This paper investigated the feasibility of sonication as an advanced treatment method for drinking water production and used comprehensive indexes of water quality to examine its efficiency. Results show that sonicati...This paper investigated the feasibility of sonication as an advanced treatment method for drinking water production and used comprehensive indexes of water quality to examine its efficiency. Results show that sonication significantly reduces the toxicity of water. Sonication with 5 W/L at 90 kHz lasting for 30 rain decreases the water SUVA and the disinfection byproduct formation potential （DBPFP） by 38.7% and 27. 2% respectively. Sonication also decreases the UV254 by more than 50% through destroying unsaturated chemical bonds. Higher sound intensity and higher frequency benefit the reduction of TOC and UV254. Besides, sonication significantly increases the affinity of organics with granular activated carbon （ GAC ） , and thus the hybrid sonication-GAC method reduces the water TOC, COD, UV254, and DBPFP by 78.3%, 69.4%, 75.7%, and 70.0% respectively. Therefore, sonication and the hybrid sonication-GAC metbod are proposed as advanced treatment methods for drinking water.展开更多
Cyproterone acetate (CPA) is a steroidal synthetic progestagen and anti-androgenic compound widely administered in prostate cancer which has been evidentially correlated with a severe hepatotoxic potency. Three male p...Cyproterone acetate (CPA) is a steroidal synthetic progestagen and anti-androgenic compound widely administered in prostate cancer which has been evidentially correlated with a severe hepatotoxic potency. Three male patients aged 78-83 years are presented, in whom severe hepatotoxic reactions emerged after CPA administration. Patients were treated with CPA at the doses of 200-300 mg/d for malignant prostate disease for 3-12 mo prior to the acute manifestation of the hepatic disease. Clinical features compatible with mixed hepatocellular and cholestatic liver disease including jaundice, white stools and dark urine, manifested in all three cases whereas encephalopathy and ascites were present in two of the patients. Other primary causes of hepatotoxicity (alcohol consumption and viral hepatitis) were also verified in two cases, and in those patients biopsy findings revealed the presence of cirrhotic lesions in liver parenchyma. Discontinuation of the therapeutic agent led to the amelioration of the clinical profile in all the patients whereas a patient died 40 d after hospital admission due to sepsis, despite acute liver disease improvement. The current article highlights the hepatotoxic potency of a widely administered therapeutic agent and illustrates the importance of clinical surveillance especially in patients with previous hepatic diseases. Three relevant cases are reported and a review of the published literature is made.展开更多
基金Sponsored by the National High Technology Research and Development Program of China(Grant No.2007AA06Z339)the National Science Foundation for Post-doctoral Scientists of China(Grant No.2006AA06Z306)
文摘This paper investigated the feasibility of sonication as an advanced treatment method for drinking water production and used comprehensive indexes of water quality to examine its efficiency. Results show that sonication significantly reduces the toxicity of water. Sonication with 5 W/L at 90 kHz lasting for 30 rain decreases the water SUVA and the disinfection byproduct formation potential （DBPFP） by 38.7% and 27. 2% respectively. Sonication also decreases the UV254 by more than 50% through destroying unsaturated chemical bonds. Higher sound intensity and higher frequency benefit the reduction of TOC and UV254. Besides, sonication significantly increases the affinity of organics with granular activated carbon （ GAC ） , and thus the hybrid sonication-GAC method reduces the water TOC, COD, UV254, and DBPFP by 78.3%, 69.4%, 75.7%, and 70.0% respectively. Therefore, sonication and the hybrid sonication-GAC metbod are proposed as advanced treatment methods for drinking water.
文摘Cyproterone acetate (CPA) is a steroidal synthetic progestagen and anti-androgenic compound widely administered in prostate cancer which has been evidentially correlated with a severe hepatotoxic potency. Three male patients aged 78-83 years are presented, in whom severe hepatotoxic reactions emerged after CPA administration. Patients were treated with CPA at the doses of 200-300 mg/d for malignant prostate disease for 3-12 mo prior to the acute manifestation of the hepatic disease. Clinical features compatible with mixed hepatocellular and cholestatic liver disease including jaundice, white stools and dark urine, manifested in all three cases whereas encephalopathy and ascites were present in two of the patients. Other primary causes of hepatotoxicity (alcohol consumption and viral hepatitis) were also verified in two cases, and in those patients biopsy findings revealed the presence of cirrhotic lesions in liver parenchyma. Discontinuation of the therapeutic agent led to the amelioration of the clinical profile in all the patients whereas a patient died 40 d after hospital admission due to sepsis, despite acute liver disease improvement. The current article highlights the hepatotoxic potency of a widely administered therapeutic agent and illustrates the importance of clinical surveillance especially in patients with previous hepatic diseases. Three relevant cases are reported and a review of the published literature is made.
